Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies.
Related Articles
Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies.
Clin Exp Med. 2006 Mar;6(1):1-12
Authors: Dillman RO
CD20 has proven to be an excellent target for the treatment of B-cell lymphoma, first for the chimeric monoclonal antibody rituximab (Rituxantrade mark), and more recently for the radiolabelled antibodies Y-90 ibritumomab tiuxetan (Zevalintrade mark) and I-131 tositumomab […]
Filed under: radiation | No Comments »